Immune response to HIV virus linked to cancer mutations

October 25, 2017 by Federica Giannelli, University of Saskatchewan
Madison Adolph and Linda Chelico (left) uncovered how enzymes in the immune system may “go rogue” and cause cancer. Credit: David Stobbe

"Our findings could change the way we treat cancer," said microbiology professor Linda Chelico. Her research, funded by the federal agency NSERC, was recently published in Nucleic Acids Research and a related project was published in Nature Communications.

Chelico and PhD student Madison Adolph have found evidence that three enzymes in the APOBEC3 family, which guards the immune system with seven enzymes in total, may "go rogue," triggering in human DNA that may lead to over time.

The results could open up the possibility for developing inhibitors that suppress these enzymes when they malfunction, or developing special tests to monitor their levels in the body.

Scientists have previously known that these enzymes are linked to and may also appear in cancer patients not infected by viruses. But until now they had not known how the enzymes mutated the human genome.

"The enzymes we study are very important for building a defence against viruses, but some specifically activated to fight HIV infection may end up being expressed in the wrong place at the wrong time, causing unintended mutations," said Chelico.

The enzymes bind to the DNA of the HIV virus and try to mutate it to shut down the virus replication in the body. But HIV has its own defence mechanism.

Unable to fight HIV, the enzymes keep scanning human DNA and may incorrectly get turned on in the wrong cell type, causing mutations to healthy cells. This happens even in the presence of the body's repair mechanisms that are supposed to protect human DNA from damage.

"This is off-target behavior for the enzymes because they typically attack only single-stranded virus DNA," said Adolph. "We have identified for the first time the biochemical features that allow these enzymes to bind to tiny regions of human DNA that are single-stranded."

Adolph spent the past four years trying to isolate from cells the APOBEC3B, the main contributor to these mutations, and was unsuccessful for a long time. But she did not give up because she knew the process was key to understanding the mechanisms behind these enzymes.

"We were the first research team to study these enzymes outside cells, which is their natural environment. We were able to analyze how they cause mutations, instead of looking at already mutated cancer genomes as previous researchers did," said Adolph.

Despite the promising results, the researchers caution that what triggers the malfunction of the enzymes is still unknown. The U of S team has yet to establish whether the enzymes initiate cancer or make it worse by causing further mutations to the DNA of cells.

"We have started a new research phase where we mix healthy and these enzymes together in the lab to see what happens, but we are still at a very early stage," said Chelico.

Explore further: On the other hand, the immune system can also cause cancer

Related Stories

On the other hand, the immune system can also cause cancer

August 23, 2017
Infection with human papillomavirus (HPV) is the primary cause of cervical cancer and a subset of head and neck cancers worldwide. A University of Colorado Cancer Center paper describes a fascinating mechanism that links ...

An unexpected role for epigenetic enzymes in cancer

December 6, 2016
To better understand how cancer initiates and spreads, Yale associate professor of pathology Qin Yan turned to the field of epigenetics, which examines changes in the expression of genes and proteins that do not affect the ...

New studies create better understanding of cancer-spreading enzymes

December 2, 2015
As a part of the human immune system, white blood cells create a number of enzymes that help fight disease. Sometimes, these enzymes can malfunction, causing damage to the body or increasing cancer growth. Now, researchers ...

Researchers provide molecular portraits of a new cancer drug target

December 19, 2016
Unprecedented images of cancer genome-mutating enzymes acting on DNA provide vital clues into how the enzymes work to promote tumor evolution and drive poor disease outcomes. These images, revealed by University of Minnesota ...

Recommended for you

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.